Literature DB >> 33656979

Making friends out of foes: novel therapeutic approaches for haemophilia.

Catriona Mactier1, Cedric Hermans2.   

Abstract

Entities:  

Year:  2020        PMID： 33656979      PMCID： PMC7925227          DOI： 10.2450/2020.0403-20

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  10 in total

Review 1.  Consideration in hemophilia therapy selection.

Authors:  Steven Pipe
Journal:  Semin Hematol       Date:  2006-04       Impact factor: 3.851

2.  The best of times, the worst of times: a story of haemophilia.

Authors:  Christine A Lee
Journal:  Clin Med (Lond)       Date:  2009-10       Impact factor: 2.659

3.  Safety and efficacy of emicizumab and other novel agents in newborns and infants.

Authors:  Glenn F Pierce; Daniel P Hart; Radoslaw Kaczmarek
Journal:  Haemophilia       Date:  2019-07-30       Impact factor: 4.287

4.  Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.

Authors:  J Oldenburg; V Jiménez-Yuste; R Peiró-Jordán; L M Aledort; E Santagostino
Journal:  Haemophilia       Date:  2013-11-19       Impact factor: 4.287

5.  Gene therapy for hemophilia: anticipating the unexpected.

Authors:  Glenn F Pierce
Journal:  Blood Adv       Date:  2020-08-11

6.  Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?

Authors:  Glenn F Pierce; Radoslaw Kaczmarek; Declan Noone; Brian O'Mahony; David Page; Mark W Skinner
Journal:  Haemophilia       Date:  2020-09-10       Impact factor: 4.287

7.  Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study.

Authors:  Steven W Pipe; Midori Shima; Michaela Lehle; Amy Shapiro; Sammy Chebon; Katsuyuki Fukutake; Nigel S Key; Agnès Portron; Christophe Schmitt; Maria Podolak-Dawidziak; Nives Selak Bienz; Cedric Hermans; Avrita Campinha-Bacote; Anna Kiialainen; Kathelijne Peerlinck; Gallia G Levy; Victor Jiménez-Yuste
Journal:  Lancet Haematol       Date:  2019-04-16       Impact factor: 18.959

Review 8.  Tolerating Factor VIII: Recent Progress.

Authors:  Sebastien Lacroix-Desmazes; Jan Voorberg; David Lillicrap; David W Scott; Kathleen P Pratt
Journal:  Front Immunol       Date:  2020-01-10       Impact factor: 7.561

Review 9.  Bispecific Antibodies and Advances in Non-Gene Therapy Options in Hemophilia.

Authors:  Midori Shima
Journal:  Res Pract Thromb Haemost       Date:  2020-04-28

Review 10.  Hemophilia therapy: the future has begun.

Authors:  Pier Mannuccio Mannucci
Journal:  Haematologica       Date:  2020-02-14       Impact factor: 9.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.